Covered recipient · General Payments record
GAYLE KITE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$2,898.78
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,202.12 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $399.64 | 10 |
| E.R. Squibb & Sons, L.L.C. | $154.46 | 1 |
| Axsome Therapeutics, Inc. | $124.46 | 1 |
| Vanda Pharmaceuticals Inc. | $123.98 | 1 |
| Otsuka America Pharmaceutical, Inc. | $122.55 | 1 |
| Noven Pharmaceuticals, Inc. | $122.50 | 1 |
| Teva Pharmaceuticals USA, Inc. | $113.63 | 1 |
| HARMONY BIOSCIENCES LLC | $40.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.85 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107470565 | CMS |
| ABBVIE INC. | $20.80 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107470567 | CMS |
| ABBVIE INC. | $6.71 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107470569 | CMS |
| ABBVIE INC. | $7.48 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107470571 | CMS |
| ABBVIE INC. | $16.53 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107470573 | CMS |
| ABBVIE INC. | $124.03 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107470575 | CMS |
| ABBVIE INC. | $31.41 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107470577 | CMS |
| ABBVIE INC. | $125.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107470579 | CMS |
| ABBVIE INC. | $19.21 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107470581 | CMS |
| ABBVIE INC. | $22.62 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107470583 | CMS |
| Axsome Therapeutics, Inc. | $124.46 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148360122 | CMS |
| E.R. Squibb & Sons, L.L.C. | $154.46 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101271187 | CMS |
| HARMONY BIOSCIENCES LLC | $40.90 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126060516 | CMS |
| Noven Pharmaceuticals, Inc. | $122.50 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084817464 | CMS |
| Otsuka America Pharmaceutical, Inc. | $122.55 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119113483 | CMS |
| Teva Pharmaceuticals USA, Inc. | $113.63 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151539503 | CMS |
| Vanda Pharmaceuticals Inc. | $123.98 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133952266 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.